Search

Your search keyword '"Giovanni Casali"' showing total 6 results
Start Over Author "Giovanni Casali" Publisher ovid technologies (wolters kluwer health)
6 results on '"Giovanni Casali"'

1. OC71 SURGICAL TREATMENT FOR ISOLATED TRICUSPID VALVE INFECTIVE ENDOCARDITIS. 25-YEAR RESULTS

Author

F. Musumeci, Davide Pacini, M. Di Mauro, C. De Vincentiis, G. Murara, C. Beghi, Carlo Antona, Y. Dossena, G. Actis Dato, A. Della Corte, Giosuè Falcetta, Giuseppe Faggian, Giangiuseppe Cappabianca, Francesco Onorati, Filippo Benassi, Ugolino Livi, Sandro Sponga, Giovanni Casali, R. Lorusso, Andrea Biondi, Mauro Rinaldi, Giovanni Cagnoni, R. Gherli, R. Di Bortalomeo, Paolo Centofanti, Diego Cugola, Vito Margari, Fabio Barili, Franck E. Nicolini, Enrico Vizzardi, Emmanuel Villa, Massimiliano Foschi, E. Della Ratta, Samuel Mancuso, Antonio Salsano, M. Piccichè, Alberto Pozzoli, Domenico Paparella, Loris Salvador, Uberto Bortolotti, Lorenzo Galletti, Alessandro Parolari, Carla Lucarelli, Roberto Scrofani, Giovanni Mariscalco, M. De Bonis, Giuseppe Scrascia, G. Troise, F. Santini, and Daniele Maselli

Subjects
medicine.medical_specialty, Tricuspid valve, medicine.anatomical_structure, business.industry, Infective endocarditis, medicine, General Medicine, Cardiology and Cardiovascular Medicine, business, medicine.disease, Surgical treatment, Surgery
Published
2018
Full Text
View/download PDF

2. EP14 FLUID MANAGEMENT PROTOCOL APPLICATION WITH COLLOIDS ABOLITION REDUCES RE-EXPLORATION FOR BLEEDING AND BLOOD PRODUCTS USE IN CARDIAC SURGERY PATIENTS

Author

M. Pano, Salvatore Nicolardi, Giovanni Casali, D. Panzera, M. Cucurachi, M. Cazzato, L.P. De Razza, Federica Mangia, Cosimo Angelo Greco, A. Scotto di Quacquaro, Salvatore Zaccaria, L. Amorese, P. Fellini, D. Rocco, Giuseppe Scrascia, and A. Gallo

Subjects
medicine.medical_specialty, business.industry, Medicine, General Medicine, Fluid management, Cardiology and Cardiovascular Medicine, business, Protocol Application, Cardiac surgery, Surgery
Published
2018
Full Text
View/download PDF

3. VD05 BENTALL OPERATION IN BICUSPID VALVE AND ANOMALOUS LEFT CIRCUMFLEX CORONARY ARTERY

Author

Giuseppe Scrascia, A. Scotto di Quacquaro, C. Angelo Greco, Salvatore Nicolardi, D. Rocco, Salvatore Zaccaria, P. Fellini, A. Gallo, Giovanni Casali, L. Amorese, Federica Mangia, and M. Pano

Subjects
medicine.medical_specialty, business.industry, Bicuspid valve, Internal medicine, Cardiology, Medicine, LEFT CIRCUMFLEX CORONARY ARTERY, General Medicine, Cardiology and Cardiovascular Medicine, business
Published
2018
Full Text
View/download PDF

5. OC58 PRELIMINARY RESULTS OF MITRAL VALVE SURGERY IN OCTOGENARIANS

Author

Giovanni Casali, Salvatore Nicolardi, P. Vanelli, Carlo Antona, Mauro Rinaldi, Davide Ricci, Domenico Paparella, and E. Cura Stura

Subjects
medicine.medical_specialty, Multicenter study, business.industry, Medicine, General Medicine, Cardiology and Cardiovascular Medicine, business, Mitral valve surgery, Surgery
Published
2018
Full Text
View/download PDF

6. Chordoma

Author

Matthew Varacallo, Paolo Giovanni Casali, Claudia Sangalli, Silvia Stacchiotti, and Alessandro Gronchi

Subjects
Cancer Research, Pyrimidines, Spinal Neoplasms, Oncology, Sacrococcygeal Region, Benzamides, Chordoma, Imatinib Mesylate, Humans, Antineoplastic Agents, Protein Kinase Inhibitors, Skull Base Neoplasms, Piperazines
Abstract

To review developments in chordoma treatment.Recent series with prolonged follow-up show that adequate margins are necessary for surgery to be curative. Safe margins are often difficult to obtain due to the anatomical sites of chordoma: sacrum, skull base and spine. Tumors in these sites are problematic for radiation therapy as well, and this adds to the need for high doses. Hadrons have therefore been used in addition to, or instead of, photons. New photon beam techniques, e.g. intensity modulated radiation therapy and stereotactic procedures, have recently been evaluated. Although less available than photons, hadrons possess certain advantages. While chemotherapy is poorly active, recent interest has focused on molecular-targeted agents. Imatinib was shown to be active, providing mainly nondimensional tissue responses in a significant proportion of patients, which may improve symptoms and progression-free interval. Epidermal growth factor receptor targeting, anti-angiogenics, and the combination of targeted agents with chemotherapy and radiation therapy are also under scrutiny.Two major issues about local treatment remain unresolved: when to complement surgery with radiation therapy, and how best to deliver high doses of radiation therapy to the tumor tissue. Regarding systemic treatment, there is ongoing research into how to exploit molecular-targeted therapies.

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results